4.8 Article

Super long-term glycemic control in diabetic rats by glucose-sensitive LbL films constructed of supramolecular insulin assembly

Journal

BIOMATERIALS
Volume 33, Issue 33, Pages 8733-8742

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.biomaterials.2012.08.041

Keywords

Diabetes; Drug delivery; Long-term controlled release; Supramolecular insulin assembly; Layer-by-layer assembly

Funding

  1. National Natural Science Foundation of China [20704026, 51073102]
  2. Fok Ying Tung Education Foundation [122034]
  3. Program for New Century Excellent Talents in University [NCET-10-0592]
  4. Program for Changjiang Scholars and Innovative Research Team in University [IRT1163]
  5. Science & Technology Foundation for Youths of Sichuan Province [2012JQ0009]
  6. Fundamental Research Funds for the Central Universities [2010SCU22001, 2011SCU04A04]
  7. Natural Science Foundation of Jiangsu Province [BK2010248, BK2011340]

Ask authors/readers for more resources

The supramolecular assembly of porcine insulin (P-SIA) is prepared at moderate condition and monitored by Thioflavin T fluorescence to avoid the formation of mature amyloid fibrils with beta-sheet rich structure. P-SIA is characterized in terms of structure, morphology and the capability of sustained insulin release in vitro. Then, a glucose-sensitive layer-by-layer (LbL) film is fabricated with star poly[2-(dimethylamino) ethyl methacrylate] (star-PDMAEMA), glucose oxidase (GOD), catalase (CAT) and P-SIA in the form of {(Star-PDMAEMA/P-SIA)(2) + (Star-PDMAEMA/CAT)(1) + (Star-PDMAEMA/GOD)(2)}(2) + Star-PDMAEMA, in which the CAT is introduced to eliminate the aggregated H2O2 and maintain the activity of GOD in the long release time. Within the scope of the investigation, a single dose administration could provide effective glycemic control in diabetic rats for up to 295 days without hypoglycemia. The striking result is contributed both by the inherent property of P-SIA and the glucose-sensitive regulation capability of the LbL film, for which the mechanism was thoroughly investigated both in vitro and in vivo. These findings are valuable to inspire more researches to combine supramolecular insulin assembly with various functional drug delivery systems, biochemical additives, biomaterials and biomedical devices for diabetic therapy. (C) 2012 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available